行情

TCMD

TCMD

Tactile Sys Tech
NASDAQ

实时行情|Nasdaq Last Sale

44.98
+0.98
+2.23%
盘后: 44.98 0 0.00% 16:00 09/21 EDT
开盘
44.45
昨收
44.00
最高
45.32
最低
43.70
成交量
14.59万
成交额
--
52周最高
64.53
52周最低
30.31
市值
8.90亿
市盈率(TTM)
64.78
分时
5日
1月
3月
1年
5年
BRIEF-Tactile Medical Announces Acquisition Of Afflovest
reuters.com · 09/08 20:18
Tactile Medical 将出席摩根士丹利第 19 届年度全球医疗保健会议
Tactile Systems Technology, Inc. ("Tactile Medical") (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced that management will participate in the Morgan Stanley 19...
GlobeNewswire · 08/31 20:05
研究触觉系统技术的资本使用回报
After pulling data from Benzinga Pro it seems like during Q2, Tactile Systems Tech (NASDAQ:TCMD) posted sales of $51.06 million. Earnings were up 98.14%, but Tactile Systems Tech still reported an overall loss of $76.00 thousand.
Benzinga · 08/19 15:20
资本使用回报率概览：触觉系统技术
After pulling data from Benzinga Pro it seems like during Q2, Tactile Systems Tech (NASDAQ:TCMD) posted sales of $51.06 million. Earnings were up 98.14%, but Tactile Systems Tech still reported an overall loss of $76.00 thousand.
Benzinga · 08/12 15:22
Tactile Medical 将出席古根海姆 2021 年 MedTech Disruptors 峰会
MINNEAPOLIS, Aug. 04, 2021 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced that manag...
GlobeNewswire · 08/04 20:05
您是否错过了 Tactile Systems Technology（纳斯达克股票代码：TCMD）令人印象深刻的 250% 股价上涨？
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on the bright side, if...
Simply Wall St. · 08/03 13:21
触觉系统技术 (TCMD) 报告第二季度盈亏平衡收益
Zacks.com · 08/02 22:25
回顾：触觉系统技术第二季度收益
Shares of Tactile Systems Tech (NASDAQ:TCMD) were flat in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share increased 113.73% year over year to $0.07, which beat the estimate of $0.01.
Benzinga · 08/02 21:19
更多
财务预测
实际值（美元）
预测值（美元）
利润表更多
净利润（美元）
同比（%）
资产负债表更多
总资产（美元）
总负债（美元）
资产负债率（%）
现金流表更多
经营现金流（美元）
同比（%）
了解TCMD最新的财务预测，通过TCMD每股收益，每股净资产，每股现金流等数据分析Tactile Sys Tech近期的经营情况，然后做出明智的投资选择。
分析师评级

5位分析师的综合评级

强力推荐

免责声明：分析师观点仅供投资者决策参考，不构成任何买卖投资建议。

目标价格预测
分析师预测TCMD价格均价为70.00，最高价位75.00，最低价为62.00。
EPS
机构持股
总机构数: 241
机构持股: 2,309.93万
持股比例: 116.77%
总股本: 1,978.23万
类型机构数股数
增持
59
203.48万
建仓
8
19.26万
减持
42
106.36万
平仓
11
17.45万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
医疗设备、用品及经销
+0.10%
医疗设备和用品
+0.22%
高管信息
Non-Executive Chairman/Independent Director
Peter Soderberg
President/Chief Executive Officer/Director
Daniel Reuvers
Chief Financial Officer
Brent Moen
Senior Vice President/Director of Sales
Eric Pauls
Senior Vice President/Director of Marketing
Kristie Burns
Senior Vice President
Darren Wennen
Independent Director
William Burke
Independent Director
Sheri Dodd
Independent Director
Raymond Huggenberger
Independent Director
Deepti Jain
Independent Director
Richard Nigon
Independent Director
Kevin Roche
暂无数据
  • 全部
  • 财务报告
  • 内部人交易
更多
TCMD 简况
Tactile Systems Technology, Inc.是一家从事医疗设备开发和提供业务的医疗技术公司，可用于在家中治疗慢性病。该公司制造和分销Flexitouch和Entre系统，该医疗设备有助于控制淋巴水肿的症状，淋巴水肿是一种慢性累进疾病，通常是癌症治疗的意外后果。该公司还制造和分销ACTitouch系统，它是一种用于治疗静脉性腿部溃疡和慢性静脉功能不全的医疗设备。该公司产品可长期治疗慢性病。该公司提供用于家庭的产品，通过美国各地的血管、伤口和淋巴水肿诊所销售产品。该公司提供了一个在美国各地提供家庭医疗保健解决方案的平台。该公司最初的治疗重点领域是血管疾病，重点是推进治疗淋巴水肿和慢性静脉功能不全的护理。

微牛提供Tactile Systems Technology Inc(NASDAQ-TCMD)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的TCMD股票新闻，以帮助您做出投资决策。

模拟交易：模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易TCMD股票基本功能。